General
Australia’s Oxford-AstraZeneca COVID-19 vaccine choice questioned as experts highlight ‘shaky’ science
Sitting in his home in New York, Geoff Porges is a long way from his family in Orange, in regional New South Wales.
In fact, during 2020, it has never felt further away for Dr Porges, a vaccine expert of 25 years and a director of therapeutics research at the one of the world’s leading healthcare investment banks.
And although he may be a long way away, this week Dr Porges made comments that reverberated back to his country of birth.
LIVE UPDATES: Read our blog for the latest news on the COVID-19 pandemic.
On Monday night Australian time, the AstraZeneca-Oxford University vaccine candidate, one of the COVID-19 vaccines the Australian Government committed to in a multi-billion-dollar deal, released its first interim results from its phase 3…
-
Business22 hours agoBroker names 2 small cap ASX shares to buy for big returns
-
Business22 hours agoThese top ASX 200 stocks could rise 25% to 60%
-
Noosa News23 hours agoTributes continue to flow | Noosa Today
-
Noosa News22 hours agoMin Woo Lee, Adam Scott and Cameron Smith in the mix after Australian PGA opening round in Brisbane